Tandem Diabetes Care Inc (TNDM): Next-Year EPS Estimate 107.20%
As of 2026-11-12, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 107.20%. Featured in our EPS revision report on 2026-07-20.
On 2026-11-12, analyst consensus for TNDM's next-year EPS growth shifted from 107.23% to 107.20% — a negative change of 0.03 percentage points. Current-year growth is projected at 58.60%.
What's Driving This
TNDM shares have risen primarily on a sharp upward revision in next-year EPS growth estimates, which moved from 113.09% to 119.85% on July 16,
Generated 2026-09-21 from news as of 2026-09-21
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 107.20%
- EPS growth this year
- 58.60%
- EPS next quarter (est)
- $0.10
- Last price
- $17.51
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 107.20% | 58.60% | $0.10 | $17.51 |
| 2026-11-11 | 107.23% | 58.60% | $0.10 | $18.77 |
| 2026-11-10 | 106.07% | 58.28% | $0.10 | $18.71 |
| 2026-11-09 | 106.07% | 58.28% | $0.10 | $18.17 |
| 2026-11-07 | 109.60% | 58.06% | $0.11 | $16.91 |
| 2026-11-06 | 109.60% | 58.06% | $0.11 | $16.91 |
| 2026-11-05 | 119.06% | 53.99% | -$0.25 | $17.99 |
| 2026-11-04 | 119.06% | 53.99% | -$0.25 | $19.05 |
| 2026-11-03 | 119.06% | 53.99% | -$0.25 | $17.65 |
| 2026-11-02 | 119.06% | 53.99% | -$0.25 | $18.67 |
| 2026-10-31 | 119.06% | 53.99% | -$0.25 | $19.11 |
| 2026-10-30 | 119.06% | 53.99% | -$0.25 | $19.11 |
| 2026-10-29 | 119.06% | 53.99% | -$0.25 | $19.79 |
| 2026-10-28 | 119.06% | 53.99% | -$0.25 | $19.68 |
| 2026-10-27 | 119.06% | 53.99% | -$0.25 | $19.22 |
| 2026-10-26 | 119.06% | 53.99% | -$0.25 | $18.90 |
| 2026-10-23 | 119.06% | 53.99% | -$0.25 | $17.43 |
| 2026-10-22 | 119.06% | 53.99% | -$0.25 | $17.15 |
| 2026-10-21 | 119.06% | 53.99% | -$0.25 | $16.35 |
| 2026-10-20 | 119.06% | 53.99% | -$0.25 | $16.52 |
| 2026-10-19 | 119.06% | 53.99% | -$0.25 | $16.38 |
| 2026-10-16 | 119.06% | 53.99% | -$0.25 | $16.24 |
| 2026-10-15 | 119.06% | 53.99% | -$0.25 | $16.52 |
| 2026-10-14 | 119.06% | 53.99% | -$0.25 | $16.01 |
| 2026-10-13 | 119.06% | 53.99% | -$0.25 | $16.65 |
| 2026-10-12 | 119.09% | 53.98% | -$0.25 | $16.45 |
| 2026-10-11 | 119.09% | 53.98% | -$0.25 | $16.11 |
| 2026-10-10 | 119.09% | 53.98% | -$0.25 | $16.11 |
| 2026-10-09 | 119.09% | 53.98% | -$0.25 | $16.11 |
| 2026-10-08 | 119.09% | 53.98% | -$0.25 | $15.68 |
Reports Featuring TNDM
Recent News
- Tandem Diabetes Care names next CEOMedTech Dive
- Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026Business Wire
- Tandem Diabetes Care, Inc. Q2 2026 Earnings Call SummaryMoby
- Tandem to file tubeless insulin pump with FDA this quarterMedTech Dive
- Tandem Diabetes Care, Inc. Q1 2026 Earnings Call SummaryMoby
- Tandem Diabetes Care Announces First Quarter 2026 Financial ResultsBusiness Wire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Tandem Diabetes Care Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 107.20%, based on analyst consensus.
When was the latest EPS estimate revision for TNDM?▾
The most recent revision occurred on 2026-11-12, when analysts adjusted the next-year EPS growth estimate from 107.23% to 107.20%.
What sector and industry does Tandem Diabetes Care Inc belong to?▾
Tandem Diabetes Care Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNDM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tandem Diabetes Care Inc (TNDM) appears here because it was detected by our daily top-EPS-revision-performer screen.